UnitedHealth posts Q3 beat and raises 2026 profit outlook to at least $20.50/share; shares jump premarket
What happened
UnitedHealth Group reported third-quarter 2026 adjusted earnings of $4.69 per share, well above the roughly $4.14 consensus, and up from $2.92 a year earlier. Net income surged to $4.11 billion ($4.56/share) from $2.35 billion ($2.59/share) a year ago. Revenue of $112.69 billion edged past the ~$111.4 billion consensus but slipped slightly from $113.16 billion a year earlier. The key driver was cost control: the medical cost ratio improved to 88.4% versus ~89.7-89.9% expected and 89.9% a year ago, as plan design, pricing, and exits from unprofitable products took hold. UnitedHealth raised full-year 2026 adjusted EPS guidance to at least $20.50, up from $19.50-$20.00 and above the ~$19.80-$19.86 consensus. Shares rose 3-5% in premarket trading.
Why it matters & what’s next are part of Pro, along with the audio summary.
Start your free 14-day trialWho’s affected
- UnitedHealth Group (UNH) - beat-and-raise quarter, shares up 3-5% premarket, lifting Dow futures
- Managed-care peers (HUM, CVS, CI, ELV) - positive read-through on medical-cost trends and Medicare Advantage margin recovery
- Healthcare sector broadly - UNH is a Dow component and the largest U.S. health insurer, so the result supports healthcare sentiment on a heavy bank-earnings day